|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,149.00 KRW | -4.73% |
|
-12.89% | -30.36% |
| 05-20 | Aprogen Medicines Inc. announced that it expects to receive KRW 10 billion in funding from N2Tech Co.,Ltd | CI |
| 25-07-24 | N2Tech Co.,Ltd announced that it has received KRW 10 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Semiconductor Equipment & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 26.66M | - | - | - | - | - |
| 676B | |||||
| 392B | |||||
| 182B | |||||
| 83.15B | |||||
| 23.12B |
- Stock Market
- Stocks
- A227950 Stock
- Charts N2Tech Co.,Ltd
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
